Faze Med­i­cines launch­es with $81M Se­ries A, Al­ny­lam vet head­ing sci­ence in play at bio­mol­e­c­u­lar con­den­sates

Once most­ly un­known to the larg­er sci­en­tif­ic world, the field of bio­mol­e­c­u­lar con­den­sates — cel­lu­lar struc­tures that could have big im­pli­ca­tions on neu­rode­gen­er­a­tive re­search — has seen …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER